Background: The contribution of traditional vascular risk factors to cognitive impairment and dementia is well known. However, in order to obtain possible targets for prevention of vascular cognitive impairment (VCI), it may be important to identify other early and noninvasive markers in asymptomatic middle-aged adults. The calculation of middle cerebral artery-pulsatility index (MCA-PI) is an ultrasonologic, noninvasive, validated and easily reproducible technique to assess increased distal resistance to blood flow. This study aims to assess the relationship between MCA-PI, microstructural white matter (WM) integrity and cognition in a middle-aged asymptomatic population. Methods: Ninety-five participants from the Barcelona-Asymptomatic Intracranial Atherosclerosis (AsIA) neuropsychology study were included. Subjects were 50-65 years old, free from dementia and without history of vascular disease. Transcranial color-coded duplex ultrasound examination was performed to assess MCA-PI as a measure of vascular resistance. WM integrity was evaluated by fractional anisotropy (FA) measurements of diffusion tensor images (DTI) acquired on a 3T-MRI. The neuropsychological battery was specifically selected to be sensitive to VCI, and included tests that were grouped into six cognitive domains: executive functioning, attention, verbal fluency, memory, visuospatial skills and psychomotor speed. A multivariate linear regression model adjusted for age, gender, years of education, diabetes and hypertension was performed. Results: MCA-PI was significantly associated with WM disintegration in different tracts (fornix, corticospinal and anterior thalamic), all p < 0.05 uncorrected. Both mean MCA-PI and mean FA of those significant tracts were independently associated with poor performance in attention, psychomotor speed, and visuospatial skills after adjustment for age, gender, years of education, and vascular risk factors (all p < 0.05). MCA-PI was independently associated with lower scores in all cognitive domains, except for visuospatial skills. Conclusions: Our data suggest that MCA-PI may be related to WM disintegration and early vascular cognitive impairment in middle-aged subjects. Although further prospective studies are needed to provide evidence for its validity in longitudinal studies, our results support the proposal of including MCA-PI as part of clinical assessment in order to identify targets for VCI prevention.

Keywords:
Vascular cognitive impairment, Pulsatility index, Vascular resistance, Diffusion tensor imaging
1.
Okonkwo OC, Cohen RA, Gunstad J, Tremont G, Alosco ML, Poppas A: Longitudinal trajectories of cognitive decline among older adults with cardiovascular disease. Cerebrovasc Dis 2010;30:362-373.
2.
Knopman D, Boland LL, Mosley T, Howard G, Liao D, Szklo M, et al: Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001;56:42-48.
3.
Miralbell J, López-Cancio E, López-Oloriz J, Arenillas JF, Barrios M, Soriano-Raya JJ, Galán A, Cáceres C, Alzamora M, Pera G, Toran P, Dávalos A, Mataró M: Cognitive patterns in relation to biomarkers of cerebrovascular disease and vascular risk factors. Cerebrovasc Dis 2013;36:98-105.
4.
Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S; American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia: Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American heart association/American stroke association. Stroke 2011;42:2672-2713.
5.
Jokinen H, Kalska H, Ylikoski R, Madureira S, Verdelho A, Gouw A, et al: MRI-defined subcortical ischemic vascular disease: baseline clinical and neuropsychological findings. The LADIS Study. Cerebrovasc Dis 2009;27:336-344.
6.
Koski L: Validity and applications of the Montreal cognitive assessment for the assessment of vascular cognitive impairment. Cerebrovasc Dis 2013;36:6-18.
7.
Gregoire SM, Smith K, Jager HR, Benjamin M, Kallis C, Brown MM, Cipolotti L, Werring DJ: Cerebral microbleeds and long-term cognitive outcome: longitudinal cohort study of stroke clinic patients. Cerebrovasc Dis 2012;33:430-435.
8.
Vernooij MW, Arfan Ikram M, Vrooman HA, Wielopolski PA, Krestin GP, Hofman A, Niessen WJ, Van der Lugt A, Breteler MMB: White matter microstructural integrity and cognitive function in a general elderly population. Arch Gen Psychiatry 2009;66:545-553.
9.
Sharma VK, Tsivgoulis G, Lao AY, Malkoff MD, Alexandrov AV: Noninvasive detection of diffuse intracranial disease. Stroke 2000;38:3175-3181.
10.
Mitchell GF, van Buchem MA, Sigurdsson S, Gotal JD, Jonsdottir MK, Kjartansson O, Garcia M, Aspelund T, Harris TB, Gudnason V, Launer LJ: Arterial stiffness, pressure and flow pulsatility and brain structure and function: the Age, Gene/Environment Susceptibility - Reykjavik study. Brain 2011;134:3398-3407.
11.
Roher A, Garami Z, Alexandrov A, Kokjohn T, Esh C, Kalback W, Walter M, Vedders L, Wilson J, Sabbagh M, Beach T: Interaction of cardiovascular disease and neurodegeneration: transcranial Doppler ultrasonography and Alzheimer's disease. Neurol Res 2006;28:672-678.
12.
Roher AE, Garami Z, Tyas SL, Maarouf CL, Kokjohn TA, Belohlavek M, Vedders M, Connor D, Sabbagh M, Beach T, Emmerling M: Transcranial Doppler ultrasound blood flow velocity and pulsatility index as systemic indicators for Alzheimer's disease. Alzheimers Dement 2011;7:445-455.
13.
Sierra C, de la Sierra A, Chamorro A, Larrousse M, Domenech M, Coca A: Cerebral hemodynamics and silent cerebral white matter lesions in middle-aged essential hypertensive patients. Blood Press 2004;13:304-309.
14.
Xiong YY, Mok V, Wong A, Leung T, Chen XY, Chu WC, Soo Y, Fu JH, Ding D, Hong Z, Wong KS: Evaluation of age-related white matter changes using transcranial Doppler ultrasonography. J Neuroimaging 2011, DOI: 10.1111/j.1552-6569.2011.00639.x.
15.
Webb AJS, Simoni M, Mazzucco S, Kuker W, Schulz U, Rothwell PM: Increased cerebral arterial pulsatility in patients with leukoaraiosis: arterial stiffness enhances transmission of aortic pulsatility. Stroke 2012;43:2631-2636.
16.
Mok V, Ding D, Fu J, Xiong Y, Chu W, Wang D, Abrigo J, Yang J, Wong A, Zhao Q, Guo Q, Hong Z, Wong KS: Transcranial Doppler ultrasound for screening cerebral small vessel disease: a community study. Stroke 2012;43:2791-2793.
17.
Purkayastha S, Fadar O, Mehregan A, Salat DH, Moscufo N, Meier DS, Guttmann CRG, Fisher NDL, Lipsitz LA, Sorond FA: Impaired cerebrovascular hemodynamics are associated with cerebral white matter damage. J Cereb Blood Flow Metab 2014, DOI: 10.1038/jcbfm.2013.180.
18.
López-Olóriz J, López-Cancio E, Arenillas JF, Hernández M, Jiménez M, Dorado L, Barrios M, Soriano-Raya JJ, Miralbell J, Cáceres C, Forés R, Pera G, Dávalos A, Mataró M: Asymptomatic cervicocerebral atherosclerosis, intracranial vascular resistance and cognition: the AsIA-neuropsychology study. Atherosclerosis 2013;230:330-335.
19.
Vernooij MW, Ikram MA, Tanghe HL, Vincent AJ, Hofman A, Krestin GP, van der Lugt A: Incidental findings on brain MRI in the general population. N Engl J Med 2007;357:1821-1828.
20.
Lopez-Cancio E, Dorado L, Millan M, Reverte S, Sunol A, Massuet A, Mataro M, Galan A, Alzamora M, Pera G, Toran P, Davalos A, Arenillas JF: The population-based Barcelona-Asymptomatic Intracranial Atherosclerosis Study (ASIA): rationale and design. BMC Neurol 2011;11:22.
21.
Folstein MF, Robins LN, Helzer JE: The mini-mental state examination. Arch Gen Psychiatry 1983;40:812.
22.
Sheikh JI, Yesavage JA: Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Gerontol 1986;5:165-173.
23.
Smith SM: Fast robust automated brain extraction. Hum Brain Mapp 2002;17;143-155.
24.
Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA: MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. Am J Roentgenol 1987;149:351-356.
25.
Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitne DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM: Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23(suppl 1):S208-S219.
26.
Smith SM, Nichols TE: Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 2009;44:83-98.
27.
Mori S, Wakana S, Nagae-Poetscher LM, van Zijl PC: MRI Atlas of Human White Matter. Amsterdam, Elsevier 2005.
28.
Hamilton LS, Levitt JG, O'Neill J, Alger JR, Luders E, Phillips OR, Caplan R, Toga AW, McCracken J, Narr KL: Reduced white matter integrity in attention-deficit hyperactivity disorder. Neuroreport 2008;19:1705-1708.
29.
Davenport ND, Karatekin C, White T, Lim KO: Differential fractional anisotropy abnormalities in adolescents with ADHD or schizophrenia. Psychiatry Res 2010;181:193-198.
30.
Sasson E, Doniger GM, Pasternak O, Tarrasch R, Assaf Y: White matter correlates of cognitive domains in normal aging with diffusion tensor imaging. Front Neurosci 2013;7, 32.
31.
De la Torre J: Cerebral hemodynamics and vascular risk factors: setting the stage for Alzheimer's disease. J Alzheimer's Dis 2013;32:553-567.
32.
Tsao CW, Seshadri S, Beiser AS, Westwood AJ, Decarli C, Au R, Himali JJ, Hamburg NM, Vita JA, Levy D, Larson MG, Benjamin EJ, Wolf PA, Vasan RS, Mitchell GF: Relations of arterial stiffness and endothelial function to brain aging in the community. Neurology 2013;81:984-991.
33.
O'Sullivan M: Imaging small vessel disease: lesion topography, networks, and cognitive deficits investigated with MRI. Stroke 2010;41(10 suppl):154-158.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.